Associated Papers
Genotype-phenotype correlations and cancer risk in monogenic epidermodysplasia verruciformis.
Biglari S et al.
Journal of the European Academy of Dermatology and Venereology : Jeadv, 2026
A novel EVER1 gene mutation associated with epidermodysplasia verruciformis and multiple cutaneous malignancies.
Kim NY et al.
Journal of the European Academy of Dermatology and Venereology : Jeadv, 2023
Aggressive Squamous Cell Carcinoma in a Case of Epidermodysplasia Verruciformis Carrying a TMC6 Splice-site Mutation.
Yokoi K et al.
Acta Dermato-venereologica, 2023
Genomic analyses of 10,376 individuals in the Westlake BioBank for Chinese (WBBC) pilot project.
Cong PK et al.
Nature Communications, 2022
35618720 (PubMed )
Supplement: 41467_2022_30526_MOESM5_ESM.xlsx › Data_2
The EVER genes - the genetic etiology of carcinogenesis in epidermodysplasia verruciformis and a possible role in non-epidermodysplasia verruciformis patients.
Kalińska-Bienias A et al.
Postepy Dermatologii I Alergologii, 2016
Epidermodysplasia verruciformis.
Burger B et al.
Current Problems in Dermatology, 2014
Four mutations in Epidermodysplasia verruciformis 1 (EVER1) gene are not contributors to susceptibility in RRP.
Donfack J et al.
International Journal of Pediatric Otorhinolaryngology, 2006
Novel mutations of EVER1/TMC6 gene in a Japanese patient with epidermodysplasia verruciformis.
Tate G et al.
Journal of Human Genetics, 2004
Select a paper to view details